Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-EyeHow to use the speech recognition tool?
NCT04127006
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS)
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).
Type: Observational
Status of the trial: Active, Recruiting
Orphan Drug Recognition: No
Inclusion
- Opening Date: 0000-00-00
- Closing Date: 0000-00-00
Criteria
Children: No
Adults: Yes
Funder Type: public
HCP: Principal investigators
- RÉFÉRET National Hospital of Ophthalmology of Quinze-Vingts, Paris, France
- Ghent University Hospital, Ghent, Belgium
- Radboud university medical center, Nijmegen, Netherlands
- Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
- Medical University of Lublin, Lublin, Poland
- Moorfields Eye Hospital NHS Foundation Trust
HCP: Other investigators
Within ERN-EYE members
Principal investigators
Other investigators
Workgroups
Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
